Accumulating evidence has suggested that cooperation of oncogenic activation and the host responses is important for cancer development. In gastric cancer, activation of Wnt signaling appears to be a major oncogenic pathway that causes tumorigenesis. In the chronic gastritis caused by Helicobacter pylori infection, cyclooxigenase-2 induces prostaglandin E 2 (PGE 2 ) biosythesis, which plays an important role in tumorigenesis. We constructed a series of mouse models and investigated the role of each pathway in the gastric tumorigenesis.
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Gastric cancer is the second most common cause of cancer-related death worldwide. 1 Infection with Helicobacter pylori is associated with gastric cancer development, and the International Agency for Research on Cancer (IARC) classified Helicobacter pylori as a class I carcinogen. 2 Accumulating evidence has indicated that chronic inflammatory response associated with infectious disease is a critical component of tumor development. 3 Moreover, it has been shown that infections are responsible for more than 15% of all malignant cancers worldwide, including the association between H. pylori infection and gastric cancer. 4 Notably, host genetic variants in cytokine genes are related to responsiveness to H. pylori infection and the susceptibility to gastric cancer development. [5] [6] [7] Specific polymorphisms of interleukin (IL)-1, an important inflammatory cytokine and a potent inhibitor of gastric acid secretion, contribute to intestinal-type gastric cancer progression. 8 Polymorphisms in tumor necrosis factor (TNF)-, IL-1 receptor antagonist, and IL-10 also influence gastric cancer development, [8] [9] [10] while polymorphisms in the IL-8 promoter have been linked to diffuse-type gastric cancer. 11 These results suggest that the response of the host cytokine network to H. pylori infection is an important factor for gastric cancer development.
On the other hand, several somatic alterations that activate oncogenic pathways have been identified in human gastric cancer. For example, allelic loss or mutations in p53 are detected in 60% or 30-50% of gastric cancers, respectively, 12 while mutations in the -catenin gene is detected in 30% of the Wnt-activated subgroup of gastric cancer. 13 TGF- type II receptor gene is recognized as a tumor suppressor, and mutations have been found in gastric cancer associated with microsatellite instability (MSI). 14, 15 Moreover, about 15% of gastric cancers show expression of both epidermal growth factor (EGF) and EGF receptor (EGFR), 4 suggesting activation of the EGFR signaling pathway. 16 Taken together, these results indicate that both infection-associated inflammatory responses and oncogenic activation by genetic alterations are required for gastric cancer development.
To date, many genetic mouse models have recapitulated some of the developmental stages associated with intestinal-type gastric cancer, such as gastritis, atrophy, mucous cell metaplasia, dysplasia, and invasion. 17 These models are useful for examining the phenotypic changes caused by individual genetic alterations. In addition to these models, we constructed a series of transgenic mouse models to investigate the role of oncogenic and inflammatory pathways, such as Wnt, BMP, and PGE 2 signaling, in gastric epithelial differentiation, inflammation, and tumor development.
Activation of Wnt signaling in gastric mucosa

Wnt activation in human gastric cancer
Canonical Wnt signaling (Wnt/-catenin signaling) is a critical pathway in the regulation of development as well as in tumorigenesis. 18 When Wnt signaling is in a resting state, cytoplasmic -catenin is phosphorylated by GSK-3 within a complex containing APC and Axin, resulting in the degradation of -catenin through the ubiquitin proteasome pathway. 19 When the pathway is activated, the binding of Wnt ligands to Frizzled receptors leads to the suppression of the phosphorylation of -catenin, resulting in the to stabilization and nuclear translocation of -catenin. -Catenin then interacts with T-cell factor/lymphocyte enhancer factor (TCF/LEF) to induce transcription of Wnt target genes. In the normal intestine, Wnt All of these alterations contribute to activation of Wnt signaling.
Gastric preneoplastic lesions in K19-Wnt1 transgenic mice
To examine the role of Wnt signaling in gastric tumorigenesis, we constructed K19-Wnt1 transgenic mice that express Wnt1, one of the canonical Wnt ligands. 27 The K19 gene promoter was used to express Wnt1 in gastric epithelial cells, including undifferentiated 6 isthmal cells. 33, 34 The number of undifferentiated epithelial cells that express trefoil factor 2 (TFF2) increases significantly in the K19-Wnt1 mouse glandular stomach, indicating that Wnt signaling functions to maintain the undifferentiated status of the gastric epithelial cells (Fig.   3a, b) . Notably, aberrant cryptic foci were found on the mucosal surface of K19-Wnt1 mice, which consist of dysplastic epithelial cells with irregular branching, and increased cell proliferation and -catenin accumulation were also detected ( Fig. 3c-g ). We thus diagnosed these foci as preneoplastic lesions. However, gastric tumors do not develop in K19-Wnt1 mice, indicating that activation of Wnt signaling alone is not sufficient for gastric tumor formation. Importantly, macrophages were infiltrated into the preneoplastic lesions, whereas tissue macrophages were sparsely scattered in the normal mucosa of the same mice. It is possible that local inflammatory responses caused by spontaneous physical insult or infection might promote proliferation of Wnt-activated dysplastic cells, resulting in formation of the preneoplastic lesions.
Induction of PGE 2 pathway in gastric mucosa
Induction of COX-2/PGE 2 pathway in human gastric cancer
Epidemiological studies indicate that the regular use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with a decreased incidence of gastric cancer. [35] [36] [37] [38] NSAIDs inhibit the enzymatic activity of cyclooxygenases (COXs), which are rate-limiting enzymes for prostaglandin biosynthesis. COX enzymes catalyze synthesis of prostaglandin (PG)H 2 , which is subsequently converted to various prostanoids, including PGE 2 , by tissue-specific 7 converting enzymes. There are two COX isozymes, COX-1 and COX-2, which share a high degree of structural and enzymatic homology. COX-1 is constitutively expressed in most tissues and is considered to be responsible for maintaining physiological levels of prostaglandin biosynthesis, 39 while COX-2 expression is induced by inflammation and in tumor tissues by cytokines and growth factors. [40] [41] [42] Induction of COX-2 is found in approximately 70% of gastric cancer, predominantly in intestinal-type gastric cancer, whereas COX-1 expression is not elevated. [43] [44] [45] Moreover, the level of COX-2 expression in gastric cancer correlates with the tumor size, depth of invasion and lymph-node metastasis.
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Microsomal PGE synthase-1 (mPGES-1) is an inducible enzyme that converts PGE 2 from PGH 2 , and is functionally coupled with COX-2. 49 Simultaneous induction of COX-2 and mPGES-1 has been observed in a variety of cancers, including gastric cancer, suggesting that the inflammatory PGE 2 pathway is induced in these tumors (Fig. 1) . [50] [51] [52] [53] Consistently, the PGE 2 level is found to be significantly increased in gastric cancer 47 , and the COX-2 and PGE 2 level is associated with the H. pylori infection status, 54, 55 indicating that H. pylori infection causes induction of the PGE 2 pathway (Fig. 1) . These results suggest that the COX-2/PGE 2 pathway plays a key role in H. pylori infection-associated inflammation in gastric cancer development. 
Suppression of gastric cancer by COX-2 inhibition in animal models
Gastric metaplasia in K19-C2mE transgenic mice
To examine the effect of PGE 2 pathway activation in the gastric mucosa, we constructed another transgenic mouse model, K19-C2mE, which expresses both COX-2 and mPGES-1 simultaneously in gastric epithelial cells.
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K19-C2mE mice developed hyperplasia in the gastric mucosa, which was suppressed by treatment of the mice with a COX-2 selective inhibitor, NS-398 or meloxicam (Fig. 4a, b) . 34, 63 Histologically, the major cell type involved in the hyperplasia were mucous cells, which was similar to the findings in the spasmolytic polypeptide/TFF2-expressing metaplasia or SPEM (Fig. 4c, d) . 34, 64 SPEM is characterized by the presence of TFF2 immunoreactive cells, which is morphologically similar to those of Brunner's gland. Since SPEM was associated with greater than 90% of the resected gastric cancers analyzed in three studies, [64] [65] [66] it is suggested that SPEM is a putative preneoplastic metaplasia in the stomach. 67 In other animal models, SPEM 9 development was also found in the stomach of Helicobacter-infected mice, gastrin gene knockout mice, and in Stat3-activating gp130 mutant mice. [68] [69] [70] Notably, SPEM in these mouse models was accompanied by inflammatory responses. Importantly, disruption of the TNF- gene in K19-C2mE mice results in the suppression of inflammatory responses and SPEM development, suggesting that TNF--associated inflammation plays an essential role in SPEM formation (Fig. 4e-g ).
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Oncogenic activation and PGE 2 pathway in gastric tumorigenesis
Gastric dysplastic tumors in K19-Wnt1/C2mE transgenic mice
Compound K19-Wnt1/C2mE transgenic mice were generated by crossing K19-Wnt1 mice and K19-C2mE mice, in which both Wnt and PGE 2 pathways are activated simultaneously in the gastric mucosa.
27
K19-Wnt1C2mE mice develop large gastric tumors in the glandular stomach (Fig. 5a, b) , while no such tumors are found in either simple K19-Wnt1 or K19-C2mE transgenic mice. Histologically, gastric tumors in the K19-Wnt1/C2mE mice (hereafter Gan mice for gastric neoplasia) consist of dysplastic epithelial cells with nuclear stratification and irregularly branched tubules (Fig. 5c) . Tumor epithelial cells showed increased nuclear accumulation of -catenin and increased Ki-67 labeling, indicating promotion of Wnt activity and an increased proliferation of tumor cells, respectively (Fig. 5e) .
Increased capillary vessels were also found in the tumor stroma, which was caused by enhanced angiogenesis through the tumor-stroma interaction (Fig. 5f, g ). 72 Interestingly, part of the activated stromal fibroblasts in Gan mouse tumors were derived from bone marrow, thus suggesting that the bone marrow cells contribute to the formation of the gastric cancer microenvironment. 72 Notably, TFF2-expressing SPEM was found adjacent to the dysplastic tumor tissue, 27 showing a similar histology to human gastric cancer (Fig. 5h) . 
Gastric hamartomas in K19-Nog/C2mE transgenic mice
Juvenile polyposis syndrome (JPS) is characterized by hereditary gastrointestinal hamartomatous polyposis, 73 and a subset of JPS is caused by germline mutations in the BMP receptor type IA gene (BMPR1A). 74 BMP signaling through its type I and II receptors leads to the phosphorylation of Smad 1,5, and 8, resulting in formation of a complex with Smad4, which induces transcription of target genes. 75 BMP signaling inhibits epithelial cell proliferation and promotes differentiation (Fig. 1) , and suppression of BMP signaling in the mouse intestine results in JPS-type hamartomatous polyp development, 76-78 elongated villi and crypt fission. Importantly, the K19-Nog/C2mE mice developed large tumors in the glandular stomach (Fig.   6a) , suggesting that induction of the PGE 2 pathway is required for tumor formation in the BMP-suppressed gastric mucosa. Histologically, K19-Nog/C2mE mouse gastric tumors are not dysplastic, but consist of irregular branching of the epithelial cell layers, combined with the formation of dilated cysts filled with mucin (Fig. 6b, c) . Such histological characteristics are distinct from the dysplastic gastric tumors of Gan mice (Fig. 5c) , but are typical of the hamartomas of JPS patients. 80, 81, 83 These results indicate that the suppression of BMP signaling associated with PGE 2 induction causes gastric hamartoma development.
These results of compound mutant mice indicate that the type of genetic alteration, such as Wnt activation or BMP suppression, determines the histological type of tumors, such as adenocarcinoma or hamrtoma. 84 On the other hand, induction of the PGE 2 pathway promotes gastric tumor formation regardless of the genetic or histological types.
Gene expression profiles of mouse models and human gastric cancer
Gan mice and K19-Nog/C2mE mice develop gastric tumors caused by genetic alterations similar to those found in human gastric cancer and hamartomas, respectively. However, it is still important to compare gene expression profiles of mouse tumors with those of human cancer in order to examine whether these models really recapitulate human gastric tumors.
We have measured mRNA expression levels using the Affymetrix GeneChip system, which includes 21,066 Entrez genes and 5,324 other sequences. 85 Genome-scale overview of the microarray data revealed that expression changes in the three models, K19-C2mE and K19-Wnt1/C2mE (Gan), and K19-Nog/C2mE mice are quite similar, whereas over-expression of Wnt1 or Noggin in K19-Wnt1 or K19-Nog mice, respectively, showed expression changes in a small portion of genes (Fig. 7a) . These results suggest that most of the expression changes in Gan gastric tumors and K19-Nog/C2mE hamartomas are caused by induction of PGE 2 pathway, rather than by Wnt activation or BMP suppression. In other words, a small number of genes that are upregulated or downregulated by Wnt activation or BMP 13 suppression are important for determining the tumor phenotype.
Gene expression signatures of human gastric cancer 86 and breast cancer 87 retrieved from the Stanford Microarray Database, 88 colon cancer from the NCBI GEO (accession GSE5206), and lung tumors 90 retrieved from the United States National Cancer Institute website 91 can be plotted to distinct areas in a 3D figure based on the calculations of principal component analysis using the selected genes (Fig. 7b) . Importantly, expression signatures of (Fig. 1) . (Fig. 1) . Further studies using these mouse models will be useful for elucidating the role of oncogenic activation and host responses in gastric tumorigenesis at the molecular level.
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